Search

Your search keyword '"Michael A. McGuckin"' showing total 227 results

Search Constraints

Start Over You searched for: Author "Michael A. McGuckin" Remove constraint Author: "Michael A. McGuckin"
227 results on '"Michael A. McGuckin"'

Search Results

1. Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis

2. Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis

3. MUC13 Cell Surface Mucin Limits Salmonella Typhimurium Infection by Protecting the Mucosal Epithelial BarrierSummary

4. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and AutophagySummary

5. Gut microbiota shape the inflammatory response in mice with an epithelial defect

6. Influence of the MUC1 Cell Surface Mucin on Gastric Mucosal Gene Expression Profiles in Response to Helicobacter pylori Infection in Mice

7. Enterococcus faecalis AHG0090 is a Genetically Tractable Bacterium and Produces a Secreted Peptidic Bioactive that Suppresses Nuclear Factor Kappa B Activation in Human Gut Epithelial Cells

8. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis

9. Supplementary Data from Lynch Syndrome–Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry

10. Data from Lynch Syndrome–Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry

11. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and AutophagySummary

12. Effect of Different Volumes of Interval Training and Continuous Exercise on Interleukin-22 in Adults with Metabolic Syndrome: A Randomized Trial

13. Oral Delivery of β-Lactoglobulin-Nanosphere-Encapsulated Resveratrol Alleviates Inflammation in Winnie Mice with Spontaneous Ulcerative Colitis

14. A Novel Role for Interleukin-22 in Suppressing Major Histocompatibility Complex II in Mucosal Epithelial Cells

15. CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin

16. Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

17. Gut microbiota shape the inflammatory response in mice with an epithelial defect

18. pH - Responsive colloidal carriers assembled from β-lactoglobulin and Epsilon poly-L-lysine for oral drug delivery

21. Secreted NF-κB suppressive microbial metabolites modulate gut inflammation

22. Infection’s Sweet Tooth: How Glycans Mediate Infection and Disease Susceptibility

23. Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins

24. The cell surface mucin MUC1 limits the severity of influenza A virus infection

25. Mucoadhesive functionality of cell wall structures from fruits and grains: Electrostatic and polymer network interactions mediated by soluble dietary polysaccharides

26. Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies

27. Goblet cells as mucosal sentinels for immunity

28. The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse

29. Airway Mucus Hyperconcentration in Non–Cystic Fibrosis Bronchiectasis

30. Secreted microbial metabolites modulate gut immunity and inflammatory tone

31. Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway

32. Airways Mucus Pathogenesis in Patients with Non-Cystic Fibrosis Bronchiectasis and Primary Ciliary Dyskinesia

33. Fibre Intake Is Independently Associated with Increased Circulating Interleukin-22 in Individuals with Metabolic Syndrome

34. Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon

35. Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease?

36. MUC13 overexpression in renal cell carcinoma plays a central role in tumor progression and drug resistance

37. Enhanced colloidal stability, solubility and rapid dissolution of resveratrol by nanocomplexation with soy protein isolate

38. FUT2genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis

39. MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target

40. One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease

41. Effect of MUC1 length polymorphisms on the NLRP3 inflammasome response of human macrophages

42. 390 THIOGUANINE INHIBITS COLORECTAL TUMORIGENESIS VIA β-CATENIN SIGNALLING IN INTESTINAL EPITHELIAL CELLS INDEPENDENTLY OF IMMUNOSUPPRESSION OR AUTOPHAGY

43. Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis

44. A peculiar case of Campylobacter jejuni attenuated aspartate chemosensory mutant, able to cause pathology and inflammation in avian and murine model animals

45. MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity

46. CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin

47. Mucin gel assembly is controlled by a collective action of non-mucin proteins, disulfide bridges, Ca2+-mediated links, and hydrogen bonding

48. Epithelial Sel1L is required for the maintenance of intestinal homeostasis

49. Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes

50. Matrix Metalloproteinases Vary with Airway Microbiota Composition and Lung Function in Non–Cystic Fibrosis Bronchiectasis

Catalog

Books, media, physical & digital resources